Although the first of many GLP-1 agonists exenatide, brand Byetta was approved for type 2 diabetes in 2005, poison centers did not handle many exposure cases until several of these agents were approved for weight loss, and their popularity skyrocketed
Dauvermann MR, Lee G, Dawson N
N Engl J Med 384(12):11131124 Osaka T, Endo M, Yamakawa M, Inoue S (2005) Energy expenditure by intravenous administration of glucagon-like peptide-1 mediated by the lower brainstem and sympathoadrenal system
We welcome walk-ins and offer same-day appointments for fast, efficient care
Endogenous levels of GHK-Cu decline with age, a phenomenon that has prompted research interest in topical and investigational injectable formulations for potential skin regeneration, wound repair, and anti-inflammatory effects